文献速递血液透析通路

免疫抑制治疗在肾移植患者血液透析动静脉瘘动脉瘤样变中的作用

The Role of Immunosuppressive Therapy in Aneurysmal Degeneration of Hemodialysis Fistulas in Renal Transplant Patients.
PubMed 文献 · Ann Vasc Surg · 2021-02-07

结果显示免疫抑制组动脉瘤直径、平均流量及手术时间均显著更高,且CD3+ T淋巴细胞浸润更常见,提示免疫抑制治疗参与动脉瘤形成,支持低排斥风险患者移植后闭合AVF。

要点

  • 肾移植后免疫抑制患者的AVF静脉动脉瘤直径和平均流量显著大于未移植患者。
  • 免疫抑制组瘤壁CD3+ T淋巴细胞浸润比例显著高于未移植组(90% vs 29%)。
  • 免疫抑制治疗可能促进AVF动脉瘤形成,支持低排斥风险患者移植后闭合AVF。

核心结论

  • 接受免疫抑制治疗的肾移植患者AVF静脉动脉瘤显著更大且T淋巴细胞浸润更密集,提示免疫抑制治疗在动脉瘤形成中起作用。

主要发现

  • 免疫抑制组动脉瘤直径显著更高(P < 0.0001)。
  • 免疫抑制组平均流量显著更高(P < 0.0001)。
  • 免疫抑制组手术时间显著更长(P = 0.0007)。
  • CD3+淋巴细胞浸润在免疫抑制组显著更常见(90% vs 29%;P < 0.001)。
  • 两组间淋巴细胞定位(外膜、中膜或内膜)及类型(CD4+ vs CD8+)无显著差异。

临床怎么用

  • 对于肾移植后接受免疫抑制治疗且估计排斥风险低的患者,应考虑闭合AVF以预防动脉瘤进展。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Venous aneurysms are long-term complications of arteriovenous fistula (AVF) for hemodialysis with an estimated incidence rate of around 5-6%. The purpose of our study is to investigate the role of immunosuppressive therapy in the development of AVF aneurysms in renal transplant patients, and to determine whether AVF closure following transplantation is necessary. METHODS: Forty-six patients with symptomatic venous AVF aneurysms underwent ligation and resection of their fistulas between January 2013 and January 2020. Immunohistochemical expression of CD3, CD4, and CD8 was assessed on the surgical specimens to characterize lymphocytic infiltrate in the aneurysm wall. Patients were subdivided into "Group A"-kidney transplant patients undergoing immunosuppressive therapy which was comprised of 39 patients and "Group B"-patients who had not undergone kidney transplant which was comprised of 7 patients. The 2 groups did not significantly differ in age, sex nor risk factors for aneurysms. RESULTS: Group A showed a significantly higher aneurysm diameter (P < 0.0001), mean flow (P < 0.0001) and required a longer duration of surgery (P = 0.0007). A CD3+ lymphocytic infiltrate was significantly more common in Group A than in the Group B (90% vs 29%; P < 0.001). No significant differences in localization (adventitia, media or intima) and type (CD4+ vs CD8+) of lymphocytes were found between the 2 groups. CONCLUSION: AVF venous aneurysms were significantly larger and with a more intense T-lymphocytic infiltrate in patients undergoing immunosuppressive therapy. This finding suggests that immunosuppressive therapy plays a role in aneurysm formation, supporting the need for AVF closure in patients with an estimated low risk of rejection.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Viscardi A, Travaglino A, Del Guercio L, et al. The Role of Immunosuppressive Therapy in Aneurysmal Degeneration of Hemodialysis Fistulas in Renal Transplant Patients. Ann Vasc Surg. 2021. PMID: 33567296. doi:10.1016/j.avsg.2021.01.097

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。